• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
Spine and Biologics. very low stress. Sensible attainable quotas. Excellent product portfolio with very little gaps. Hospitals contract encourage working with MDT making business easy to convert. surgeons flock to MDT as a whole. Management is cool as long as you get small incremental business from time to time. Easy working hours and excellent work/live balance.